Ni‐Chun Tsai

1.4k citations
48 papers · 712 indexed · h-index 16
Topics
Lymphoma Diagnosis and Treatment (26 papers)Hematopoietic Stem Cell Transplantation (11 papers)Acute Lymphoblastic Leukemia research (10 papers)

In The Last Decade

Ni‐Chun Tsai

44 papers receiving 701 citations

Peers

Ni‐Chun Tsai
Comparison fields: 5 of 57
  • Oncology 382
  • Pathology and Forensic Medicine 321
  • Hematology 242
  • Immunology 130
  • Genetics 103
Replace Deepa Jagadeesh with:
Deepa Jagadeesh United States
Michela Cerno Italy
Sumithira Vasu United States
Amin Alousi United States
J. L. Harousseau France
Pierre Brousset France
Taner Demirer Türkiye
A.-M. Stoppa France
Kenneth Douglas United Kingdom
James Gajewski United States
Ni‐Chun Tsai relative to Deepa Jagadeesh United States Deepa Jagadeesh's profile →
Citations per field
00.5×1.5×
Deepa Jagadeesh · 1×
Citations per year

Countries citing papers authored by Ni‐Chun Tsai

Since Specialization
Citations

This map shows the geographic impact of Ni‐Chun Tsai's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Ni‐Chun Tsai with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Ni‐Chun Tsai more than expected).

Fields of papers citing papers by Ni‐Chun Tsai

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Ni‐Chun Tsai. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Ni‐Chun Tsai. The network helps show where Ni‐Chun Tsai may publish in the future.

Co-authorship network of co-authors of Ni‐Chun Tsai

This figure shows the co-authorship network connecting the top 25 collaborators of Ni‐Chun Tsai. A scholar is included among the top collaborators of Ni‐Chun Tsai based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Ni‐Chun Tsai. Ni‐Chun Tsai is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
#WorkIndexed citations
1 0
2 0
3 7
4 7
5 2
6 15
7 32
8 3
9 8
10 1
11 17
12 0
13 5
14 8
15 34
16 11
17 29
18 27
19 27
20 40

About Ni‐Chun Tsai

Ni‐Chun Tsai is a scholar working on Hematology, Pathology and Forensic Medicine and Transplantation, having authored 48 papers that have together received 712 indexed citations. Recurring topics across this work include Lymphoma Diagnosis and Treatment (26 papers), Hematopoietic Stem Cell Transplantation (11 papers) and Acute Lymphoblastic Leukemia research (10 papers). The work is most often cited by research in Hematology (242 citations), Transplantation (53 citations) and Pathology and Forensic Medicine (321 citations). Ni‐Chun Tsai has collaborated with scholars based in United States, Netherlands and Israel. Frequent co-authors include Joycelynne Palmer, Stephen J. Forman, Auayporn Nademanee, Sandra H. Thomas, Robert Chen, Amrita Krishnan, Len Farol, Leslie Popplewell, David Smith and Yale D. Podnos. Their work appears in journals such as Journal of Clinical Oncology, Blood and Cancer.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026